Carfilzomib can lead to cardiovascular toxicity in multiple myeloma patients

http://ift.tt/2BOIXc0 The proteasome inhibitor carfilzomib has taken on an increasing role in the treatment of multiple myeloma, but new research shows the therapy comes with the risk of cardiovascular problems in a higher than expected percentage of patients.

Advertisements

Pain-free skin patch responds to sugar levels for management of type 2 diabetes

http://ift.tt/2C9aplG Researchers have devised a biochemically formulated patch of dissolvable microneedles for the treatment of type 2 diabetes. The biochemical formula of mineralized compounds in the patch responds to blood chemistry to manage glucose automatically. In a proof-of-concept study performed with mice, the researchers showed that the chemicals interact in the bloodstream to regulate blood sugar for days at a time.

Better treatment, not more spending, saves heart attack patients, study finds

http://ift.tt/2BuMDiJ A long-term look at heart attack care and spending in America in the 21st Century shows more survival, more spending, and more variation between hospitals on both scores. And while spending on rapid angioplasty appears to be paying off, a lot of the dollars spent in the six months after a heart attack aren’t making a difference in the long-term death rate.

Better treatment, not more spending, saves heart attack patients, study finds

http://ift.tt/2BuMDiJ A long-term look at heart attack care and spending in America in the 21st Century shows more survival, more spending, and more variation between hospitals on both scores. And while spending on rapid angioplasty appears to be paying off, a lot of the dollars spent in the six months after a heart attack aren’t making a difference in the long-term death rate.